Can-Fite BioPharma Ltd. (CANF)
NYSEAMERICAN: CANF · IEX Real-Time Price · USD
2.380
+0.143 (6.37%)
May 17, 2024, 4:00 PM EDT - Market closed

Can-Fite BioPharma Statistics

Total Valuation

CANF has a market cap or net worth of $10.51 million. The enterprise value is $8.12 million.

Market Cap 10.51M
Enterprise Value 8.12M

Important Dates

The next estimated earnings date is Thursday, May 30, 2024, before market open.

Earnings Date May 30, 2024
Ex-Dividend Date n/a

Share Statistics

CANF has 4.42 million shares outstanding.

Shares Outstanding 4.42M
Owned by Insiders (%) n/a
Owned by Institutions (%) 9.57%
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 14.15
Forward PS n/a
PB Ratio 6.24
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 10.92
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.91, with a Debt / Equity ratio of 0.01.

Current Ratio 4.91
Quick Ratio n/a
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -142.50% and return on invested capital (ROIC) is -130.43%.

Return on Equity (ROE) -142.50%
Return on Assets (ROA) -79.20%
Return on Capital (ROIC) -130.43%
Revenue Per Employee $92,875
Profits Per Employee -$954,250
Employee Count 8
Asset Turnover 0.08
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +11.37% in the last 52 weeks. The beta is 0.91, so CANF's price volatility has been similar to the market average.

Beta (1Y) 0.91
52-Week Price Change +11.37%
50-Day Moving Average 2.15
200-Day Moving Average 2.24
Relative Strength Index (RSI) 65.31
Average Volume (30 Days) 19,935

Short Selling Information

Short Interest 9,926
Short Previous Month 7,465
Short % of Shares Out 1.17%
Short % of Float n/a
Short Ratio (days to cover) 0.46

Income Statement

In the last 12 months, CANF had revenue of $743,000 and -$7.63 million in losses. Loss per share was -$0.81.

Revenue 743,000
Gross Profit 200,564
Operating Income -2.21M
Pretax Income -2.06M
Net Income -7.63M
EBITDA -2.03M
EBIT -2.06M
Loss Per Share -$0.81
Full Income Statement

Balance Sheet

The company has $2.41 million in cash and $10,798 in debt, giving a net cash position of $2.40 million or $0.54 per share.

Cash & Cash Equivalents 2.41M
Total Debt 10,798
Net Cash 2.40M
Net Cash Per Share $0.54
Equity / Book Value 1.69M
Book Value Per Share 0.38
Working Capital 2.13M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$2.28 million and capital expenditures -$540, giving a free cash flow of -$2.28 million.

Operating Cash Flow -2.28M
Capital Expenditures -540
Free Cash Flow -2.28M
FCF Per Share -$0.53
Full Cash Flow Statement

Margins

Gross margin is 26.99%, with operating and profit margins of -297.73% and -1,027.46%.

Gross Margin 26.99%
Operating Margin -297.73%
Pretax Margin -277.35%
Profit Margin -1,027.46%
EBITDA Margin -273.39%
EBIT Margin -277.35%
FCF Margin -306.70%

Dividends & Yields

CANF does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth 1
Payout Ratio n/a
Buyback Yield -131.13%
Shareholder Yield -131.13%
Earnings Yield -72.61%
FCF Yield -21.67%
Dividend Details

Analyst Forecast

The average price target for CANF is $18.00, which is 656.30% higher than the current price. The consensus rating is "Strong Buy".

Price Target $18.00
Price Target Difference 656.30%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on January 9, 2023. It was a reverse split with a ratio of 1:10.

Last Split Date Jan 9, 2023
Split Type Reverse
Split Ratio 1:10

Scores

CANF has an Altman Z-Score of -17.27 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -17.27
Piotroski F-Score 4